N-(4-ブチルフェニル)-4-フルオロベンゼンスルホンアミド
|
- ￥15000 - ￥125000
- 化学名: N-(4-ブチルフェニル)-4-フルオロベンゼンスルホンアミド
- 英語名: N-(4-butylphenyl)-4-fluorobenzenesulfonamide
- 別名:N-(4-ブチルフェニル)-4-フルオロベンゼンスルホンアミド;N-(4-ブチルフェニル)-4-フルオロベンゼン-1-スルホンアミド
- CAS番号: 346692-04-4
- 分子式: C16H18FNO2S
- 分子量: 307.38
- EINECS:
- MDL Number:MFCD00784423
4物価
選択条件：
ブランド
- 富士フイルム和光純薬株式会社(wako)
- Sigma-Aldrich Japan
パッケージ
- 5mg
- 10mg
- 25mg
- 50mg
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TOC5357
- 製品説明
- 英語製品説明DC 260126
- 包装単位10mg
- 価格￥30000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TOC5357
- 製品説明
- 英語製品説明DC 260126
- 包装単位50mg
- 価格￥125000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番号SML1050
- 製品説明 ≥98% (HPLC)
- 英語製品説明DC260126 ≥98% (HPLC)
- 包装単位5mg
- 価格￥15000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番号SML1050
- 製品説明 ≥98% (HPLC)
- 英語製品説明DC260126 ≥98% (HPLC)
- 包装単位25mg
- 価格￥49680
- 更新しました2021-03-23
- 購入
| 生産者 | 製品番号 | 製品説明 | 包装単位 | 価格 | 更新時間 | 購入 |
|---|---|---|---|---|---|---|
| 富士フイルム和光純薬株式会社(wako) | W01TOC5357 | DC 260126 |
10mg | ￥30000 | 2024-03-01 | 購入 |
| 富士フイルム和光純薬株式会社(wako) | W01TOC5357 | DC 260126 |
50mg | ￥125000 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | SML1050 | ≥98% (HPLC) DC260126 ≥98% (HPLC) |
5mg | ￥15000 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | SML1050 | ≥98% (HPLC) DC260126 ≥98% (HPLC) |
25mg | ￥49680 | 2021-03-23 | 購入 |
プロパティ
貯蔵温度 :-20°C
溶解性 :DMSO: soluble20mg/mL, clear
外見 :powder
色 :white to beige
安定性： :Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
溶解性 :DMSO: soluble20mg/mL, clear
外見 :powder
色 :white to beige
安定性： :Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
安全情報
| 絵表示(GHS): |
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注意喚起語: | Warning | ||||||||||||||||||||||||||||
| 危険有害性情報: |
|
||||||||||||||||||||||||||||
| 注意書き: |
|
説明
DC260126 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, oleic, palmitoleic, and lauric acid 6 is a free fatty acid receptor 1 (FFAR1/GPR40) antagonist that inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic, olei関連商品価格
- (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)butan-2-ol hydrochloride
￥24000-222800 - 2-シクロプロピル-4-(4-フルオロフェニル)-3-キノリンメタノール
￥7500-200500 - ピオグリタゾン塩酸塩
￥11600-172700